api – Page 3 – Katalyst Wealth

Gufic Biosciences (NSE – GUFICBIO) – Nov’21 Alpha/Alpha plus stock

November 30, 2021

Dear Members, We have released 30th Nov’21: Gufic Biosciences Ltd (NSE Code – GUFICBIO) – Alpha/Alpha Plus stock for Nov’21. For details and other updates, please log into the website at the following link – https://katalystwealth.com/index.php/my-account/ Note: For any queries, mail us at [email protected] Date: 30th Nov’21 CMP – 182.25 (BSE); 181.60 (NSE) Face Value – 1.00 Rating – Positive – 4% weightage (refer rating interpretation) Introduction Gufic Biosciences Limited (GUFIC) was incorporated in the year 2000 as a public limited company…

Aarti – 5x in 2.5 years…Coverage closure update

February 19, 2021

Dear Sir, In Sep’18 we initiated coverage on Aarti, leading API manufacturer, for our Premium Members. You can read the detailed initiation report on the company at the following LINK Recently, on 5th Feb’21, we finally closed the coverage on the stock and booked complete profit in our Model Sheets as well. The company has been a great wealth creator for us and our members. We first initiated coverage on the same in Feb’14 around 27-28 odd levels (adjusted for…

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20 Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…